Pierre Yves Cremieux

Summary

Affiliation: Analysis Group
Country: USA

Publications

  1. ncbi request reprint Dose conversion and cost effectiveness of erythropoietic therapies in chemotherapy-related anemia: a Canadian application
    Pierre Cremieux
    Analysis Group, Inc, Boston, MA 02199, USA
    J Oncol Pharm Pract 12:165-78. 2006
  2. ncbi request reprint A study on the economic impact of bariatric surgery
    Pierre Yves Cremieux
    Analysis Group, Inc, 111 Huntington Ave, 10th Fl, Boston, MA 02199, USA
    Am J Manag Care 14:589-96. 2008
  3. pmc Actual and perceived impacts of tobacco regulation on restaurants and firms
    P Y Cremieux
    Department of Economics, Universite du Quebec a Montreal, Montreal, Quebec, Canada
    Tob Control 10:33-7. 2001
  4. ncbi request reprint Do drugs reduce utilisation of other healthcare resources?
    Pierre Yves Cremieux
    Analysis Group, Inc, Boston, MA 02199, USA
    Pharmacoeconomics 25:209-21. 2007
  5. ncbi request reprint The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease
    Pierre Yves Cremieux
    Analysis Group Inc, Boston, MA 02199, USA
    Curr Med Res Opin 22:2329-36. 2006
  6. doi request reprint The impact of bariatric surgery on comorbidities and medication use among obese patients
    Pierre Yves Cremieux
    Hôpital Hotel Dieu AP HP, Paris, France
    Obes Surg 20:861-70. 2010
  7. ncbi request reprint Cost-minimization analysis of once-weekly versus thrice-weekly epoetin alfa for chemotherapy-related anemia
    Pierre Y Cremieux
    Analysis Group, Inc, 111 Huntington Ave, Tenth Fl, Boston, MA 02199 7636, USA
    J Manag Care Pharm 10:531-7. 2004
  8. ncbi request reprint Public and private pharmaceutical spending as determinants of health outcomes in Canada
    Pierre Yves Cremieux
    Analysis Group, Inc, Boston, MA 02199, USA
    Health Econ 14:107-16. 2005
  9. ncbi request reprint Omitted variable bias and hospital costs
    P Y Cremieux
    Département des Sciences économiques, Universite du Quebec a Montreal, Montreal, Canada
    J Health Econ 20:271-82. 2001
  10. ncbi request reprint Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa
    Patrick Lefebvre
    Groupe d Analyse, Ltee, Montreal, Quebec, Canada
    Curr Med Res Opin 22:1929-37. 2006

Detail Information

Publications14

  1. ncbi request reprint Dose conversion and cost effectiveness of erythropoietic therapies in chemotherapy-related anemia: a Canadian application
    Pierre Cremieux
    Analysis Group, Inc, Boston, MA 02199, USA
    J Oncol Pharm Pract 12:165-78. 2006
    ..To determine the dose-conversion ratio (DCR) between epoetin alfa and darb-epoetin alfa in cancer patients and compare the treatment costs of both agents at the estimated DCRs...
  2. ncbi request reprint A study on the economic impact of bariatric surgery
    Pierre Yves Cremieux
    Analysis Group, Inc, 111 Huntington Ave, 10th Fl, Boston, MA 02199, USA
    Am J Manag Care 14:589-96. 2008
    ..To evaluate the private third-party payer return on investment for bariatric surgery the United States...
  3. pmc Actual and perceived impacts of tobacco regulation on restaurants and firms
    P Y Cremieux
    Department of Economics, Universite du Quebec a Montreal, Montreal, Quebec, Canada
    Tob Control 10:33-7. 2001
    ....
  4. ncbi request reprint Do drugs reduce utilisation of other healthcare resources?
    Pierre Yves Cremieux
    Analysis Group, Inc, Boston, MA 02199, USA
    Pharmacoeconomics 25:209-21. 2007
    ..8% in 1980 to 16.8% in 2002. Pressure to curb expenditure on drugs has increased accordingly, but containing drug expenditure might increase costs elsewhere in the healthcare sector...
  5. ncbi request reprint The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease
    Pierre Yves Cremieux
    Analysis Group Inc, Boston, MA 02199, USA
    Curr Med Res Opin 22:2329-36. 2006
    ....
  6. doi request reprint The impact of bariatric surgery on comorbidities and medication use among obese patients
    Pierre Yves Cremieux
    Hôpital Hotel Dieu AP HP, Paris, France
    Obes Surg 20:861-70. 2010
    ..The risks and benefits of bariatric surgery have rarely been evaluated in large multiyear patient samples. This study identifies the short- and long-term impact of bariatric surgery on comorbidities and medication use among obese patients...
  7. ncbi request reprint Cost-minimization analysis of once-weekly versus thrice-weekly epoetin alfa for chemotherapy-related anemia
    Pierre Y Cremieux
    Analysis Group, Inc, 111 Huntington Ave, Tenth Fl, Boston, MA 02199 7636, USA
    J Manag Care Pharm 10:531-7. 2004
    ..Whether the advantage of less-frequent administration justifies the higher EPO dosage used in the weekly regimen in terms of overall cost of care is unknown...
  8. ncbi request reprint Public and private pharmaceutical spending as determinants of health outcomes in Canada
    Pierre Yves Cremieux
    Analysis Group, Inc, Boston, MA 02199, USA
    Health Econ 14:107-16. 2005
    ....
  9. ncbi request reprint Omitted variable bias and hospital costs
    P Y Cremieux
    Département des Sciences économiques, Universite du Quebec a Montreal, Montreal, Canada
    J Health Econ 20:271-82. 2001
    ..Similarly, estimates of hospital performance are poor indicators of actual performance when data are incomplete...
  10. ncbi request reprint Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa
    Patrick Lefebvre
    Groupe d Analyse, Ltee, Montreal, Quebec, Canada
    Curr Med Res Opin 22:1929-37. 2006
    ..To evaluate the relationship between hemoglobin (Hb) level and quality of life (QOL) in anemic patients with non-dialysis chronic kidney disease receiving epoetin alfa...
  11. ncbi request reprint Hospital cost flexibility in the presence of many outputs: a public-private comparison
    Pierre Yves Cremieux
    Department of Economics, Université du, Québec a Montréal, PO Box 8888, Station Centre Ville, Montreal, Quebec, Canada H3C 3P8
    Health Care Manag Sci 8:111-20. 2005
    ..This last result suggests that there are bottlenecks in the health care system and calls for a targeted approach on the part of hospital administrators, whether public or private, in Québec or California...
  12. ncbi request reprint The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine
    Mei Sheng Duh
    Analysis Group, Inc, Boston, Massachusetts 02199, USA
    Dis Manag 10:216-25. 2007
    ..Payers may weigh smaller-than-expected cost reductions against a possible decrease in effectiveness to assess the relevance of mandatory generic switching of lamotrigine...
  13. ncbi request reprint Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy
    Jeffrey Crawford
    Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, North Carolina, USA
    Cancer 95:888-95. 2002
    ..Relationships among hemoglobin, functional status, and patient reported QOL have not been well characterized...
  14. ncbi request reprint Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients
    Andrine Swensen
    Eli Lilly and Company, Indianapolis, Indiana, USA
    J Adolesc Health 35:346.e1-9. 2004
    ..The purpose is to analyze the incidence and costs of accidents among Attention-Deficit/Hyperactivity Disorder (ADHD) patients...